Las Vegas, NV -- (SBWIRE) -- 12/23/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks:Energy Recovery, Inc.(NASDAQ:ERII),Lincoln Educational Services Corp(NASDAQ:LINC),BPZ Resources Inc(NYSE:BPZ),CytRx Corporation(NASDAQ:CYTR)
Energy Recovery, Inc.(NASDAQ:ERII) was a volume gainer of 2.39M shares and the average volume of the stock remained 549,465.00shares. The stock opened the session at $5.32 and finished at the end of the day at $5.46and the stock gained2.82%.The market capitalization of the stock remained 279.09M. The half-yearly trend of the stock remained 24.94%.Energy Recovery, Inc. is engaged in developing, manufacturing and selling of energy recovery devices and circulation pumps primarily for uses in seawater desalination plants that use reverse osmosis technology. The Company's products are sold under the trademarks.
Can Investors Bet on ERII after this News update? Find out in this Research Report
In the preceding trading session, Lincoln Educational Services Corp(NASDAQ:LINC) exchanged 2.35M shares and the average volume remained 186,786.00shares. The stock closed the session at $4.55, with the loss of-0.87%. Lincoln Educational Services Corporation is a provider of career-oriented post-secondary education.
Is LINC a Solid Investment at These Levels? Read This Report For Details
BPZ Resources Inc(NYSE:BPZ)gain4.71% and its closing price was $1.78. The volume of the stock was 2.28M shares and the average volume remained 658,009.00 shares. Yesterday, the stock traded amid the day price range of $1.71 - 1.80.The market capitalization of the stock remained 209.20M. BPZ Resources, Inc. (BPZ) is focused on the exploration, development and production of oil and natural gas in Peru and Ecuador.
What BPZ Charts Are Signaling for Traders? Find Out Here
CytRxCorporation(NASDAQ:CYTR)exchanged 2.27Mshares in the previoustrading session, and its average trading remained 3.95Mshares. It lost-4.51% and it closed the trading at $4.66. CytRx Corporation (CytRx) is a biopharmaceutical research and development company specializing in oncology. The Company's oncology pipeline includes three programs in clinical development for cancer indications: INNO-206, tamibarotene and bafetinib. INNO-206 is the Company's tumor-targeted doxorubicin conjugate.
Should CYTR a Buy or Sell Now? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)